Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Walgreen Company : Walgreen April Same-Store Sales Fall Bigger-Than-Expected 6.4%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 02:39pm CET

Walgreen Co.'s (WAG) April same-store sales fell a bigger-than-expected 6.4%--marking the fourth straight month of declines--as the drug-store chain's loss of Express Scripts Holding Co.'s (ESRX) members continued to hamper results.

Analysts polled by Thomson Reuters expected April same-store sales to fall 5.1%.

A conflict between Walgreen and Express Scripts over new contract terms erupted publicly last June, and Walgreen said it wouldn't be part of the pharmacy-benefits manager's network when their deal expired in 2011. The benefit manager's clients now have to go elsewhere to fill prescriptions.

Total sales fell 3.7% to $5.78 billion last month.

April same-pharmacy sales decreased 8.9% and missed the analysts' projected 8.6% decline.

Total pharmacy sales fell 6.3%. Prescriptions filled at same-stores declined 7.8% in April, reflecting the loss of Express Scripts members, a lower incidence of flu and more generic drug introductions. Prescriptions processed by Express Scripts comprised 12.6% of Walgreen's prescriptions a year earlier.

In the front of the store, same-store sales slipped fell 2.2% last month, compared with the analysts' flat front-end same-store sales forecast.

Total front-end sales slipped 0.5%. Customer traffic at same-stores fell 3% and average basket size increased 0.8%.

Walgreen reported in March its fiscal second-quarter earnings fell 7.7% as its exit from Express Scripts's network and a mild cold and flu season offset a 0.8% pop in total sales.

Shares closed Wednesday at $34.15 and were inactive premarket. The stock has gained 3.3% since the beginning of the year.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
11/22 WALGREENS : Makes Life Saving Naloxone Available Without Prescription in Louisia..
11/17 INTERRA RESOURCES : Walgreens sues Theranos, alleging breach of contract
11/16DJWALGREENS BOOTS ALLIANCE : Claims Theranos Voided 11.3% of Test Reports
11/15 WALGREENS BOOTS ALLIANCE INC : ex-dividend day
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/09 INTERRA RESOURCES : Walgreens sues Theranos alleging breach of contract
11/09 WALGREENS BOOTS ALLIANCE : sues Theranos alleging breach of contract
11/09DJWALGREENS BOOTS ALLIANCE : Walgreen Sues Theranos, Seeking to Recover $140 Milli..
11/08DJWALGREENS BOOTS ALLIANCE : Seeks to Recover $140 Million Investment From Therano..
More news
Sector news : Drug Retailers - NEC
11/16DJTarget Draws Back Shoppers
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/08DJCVS Warns of Prescriptions Shift, Shares Tumble
11/08DJCVS HEALTH : Warns of Prescriptions Shift, Shares Tumble on Profit Warning -- 2n..
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 121 333 M
EBIT 2017 7 626 M
Net income 2017 4 768 M
Debt 2017 8 794 M
Yield 2017 1,77%
P/E ratio 2017 18,92
P/E ratio 2018 16,60
EV / Sales 2017 0,83x
EV / Sales 2018 0,77x
Capitalization 92 198 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 92,8 $
Spread / Average Target 9,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%91 234
WALGREENS BOOTS ALLIAN..-0.50%91 234
CVS HEALTH CORP-21.36%81 860
EXPRESS SCRIPTS HOLDIN..-13.44%46 758
MCKESSON CORPORATION-27.09%32 349
CARDINAL HEALTH INC-20.45%22 702
More Results